Grand Rounds in Pediatric Nephrology – an ISN-IPNA Sister Centers initiative: HIVAN: Preventable and Treatable, Yet Can Be fatal
- 2:00 PM CEST
HIV associated nephropathy (HIVAN) was first recognized in 1984 and became a frequent cause of ERF in patients, particularly within the Black ethnic community. With the use of ART and subsequently HART from the 1990’s onward ERF from HIVAN has become much less common in the US and Europe. In children, who most often have vertically acquired disease, it is no longer seen, despite the evidence of nephrotoxicity from HART itself.
This is not the case in Africa, despite the free availability of HART and the free provision of services for diagnosis and assessment. We present a case of ERF in a teenage male patient which led to the patient’s death. This case is typical of many seen each year. Most acquire HIV through vertical transmission. Many of the children are orphans at the time of presentation. Shame and stigma lead to late diagnosis. Failure to explain the disease to young people leads to non compliance to therapy. Relative poverty means RRT is not affordable. A new approach to HIV in society in Africa is needed.
Learning objectives:
- Explain the pathogenesis and explore current and emerging treatments for HIV nephropathy.
- Describe the renal pathology associated with HIV nephropathy, including its key features and progression.
- Analyze the societal factors that influence the diagnosis, management, and treatment of HIV nephropathy, and compare how these factors vary across different continents.
Further reading:
- A review of renal disease in children with HIV infection. Jindal AK, Tiewsoh K, Pilania RK. Infect Dis (Lond). 2018 Jan;50(1):1-12. doi: 10.1080/23744235.2017.1371852. Epub 2017 Sep 8. PMID: 28885079
- Childhood HIV-associated nephropathy: 36 years later. Ray PE, Li J, Das JR, Tang P.Pediatr Nephrol. 2021 Aug;36(8):2189-2201. doi: 10.1007/s00467-020-04756-4. Epub 2020 Oct 12.PMID: 33044676
- HIV-associated nephropathy in children: challenges in a resource-limited setting. Nkoy AB, Ekulu PM, Labarque V, Van den Heuvel LP, Levtchenko EN.Pediatr Nephrol. 2023 Aug;38(8):2509-2521. doi: 10.1007/s00467-022-0581 Epub 2022 Dec 6.PMID: 36472655
Moderator
Peter Nourse (South Africa)
Speakers
Felicia Eke (Nigeria)
Brenda I. Anosike (USA)
James Pullman (USA)
Kimberly Reidy (USA)
Michael Ross (USA)
Malcolm Lewis (UK)
Tochi Uchenwa (Nigeria)